|
Kalla Krishna Prasad Gourav1, Banashree Mandal1, Anand Kumar Mishra2, V Krishna Narayanan Nayanar1
1 Department of Anaesthesia and Intensive Care, PGIMER, Chandigarh, India
2 Department of CTVS, PGIMER, Chandigarh, India
Correspondence Address:
Banashree Mandal
Room Number 4015, 4th Floor, Advanced Cardiac Centre, PGIMER, Sector 12, Chandigarh - 160 012
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/aca.ACA_33_19
Fungal infective endocarditis (IE) is uncommon in postoperative cardiac surgical patients. The fungal IE accounts for 1.3'–6.8' of all IE cases and is considered the most severe form with a mortality rate as high as 45'–50'. There are various predisposing factors for fungal IE which include congenital heart defects, cardiac interventions like pacemaker insertion, degenerative valvular heart diseases, long-term use of broad-spectrum antimicrobial therapy, and long-term use of central venous. Mortality can reach up to 100' without specific treatment. Definitive therapy necessitates surgical debridement of vegetations/mass/abscess followed by long-term treatment with antifungal agents in patients who have symptoms of heart failure despite optimum medical management. We, hereby, report a case of fungal IE which occurred after the closure of a ventricular septal defect and was treated successfully with liposomal amphotericin B.
[FULL TEXT] [PDF]*
|
Search Pubmed for
